Increased fasting serum levels of growth hormone and gastrin in patients with gastric and large bowel cancer

Annals of Gastroenterology

Volumn 15, Issue 1, 2002, Pages 72-77

  Triantafillidis, John K ^a,c   Govosdis, V ^a   Konstandellou, Evangelia ^a   Cheracakis, P ^a   Barbatzas, C ^a   Tzourmakliotis, D ^b   Sklavaina, Maria ^a  

^a Saint Panteleimon General State Hospital   (Greece)

^b Department of Gastroenterology   (Greece)

^c NONE   (Greece)

Author keywords

Gastric cancer; Gastrin; Growth hormone; IGF I; Large bowel cancer; Somatomedine

Indexed keywords

GASTRIN; GROWTH HORMONE; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; CANCER PATIENT; CARCINOGENESIS; CELL PROLIFERATION; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DIET RESTRICTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTRIN BLOOD LEVEL; GROWTH HORMONE BLOOD LEVEL; HUMAN; IMMUNORADIOMETRIC ASSAY; LARGE INTESTINE CANCER; MALE; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; STOMACH CANCER;

EID: 35648939756     PISSN: 11087471     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Okada S, Kopchick JJ. Biological effects of growth hormone and its antagonist. Trends Mol Med 2001; 7:126-132.
2. Pombo M, Pombo CM, Garcia A, Caminos E, Gualillo O, Alvarez CV, Casanueva FF, Diequez C. Hormonal control of growth hormone secretion. Horm Res 2001; 55 Suppl 1:11-16.
3. Camacho-Hubner C, Savage M. Insulin-like growth factor-I deficiency. Horm Res 2001; 55 Suppl 1:17-20.
4. Noguchi T. Protein nutrition and insulin-like growth factor system. Br J Nutr 2000; 84 Suppl 2:S241-244.
5. Cats A, Dullaart RP, Kleibeuker JH, Kuipers F, Sluiter WJ, Hardonk MJ, de Vries EG. Increased epithelial cell proliferation in the colon of patients with acromegaly. Cancer Res 1996; 56:523-526.
6. Terzolo M, Tappero G, Borretta G, Asnaghi G, Pia A, reimondo G, Boccuzzi A, Cesario F, Rovero E et al. High prevalence of colonic polyps in patients with acromegaly. Influence of sex and age. Arch Intern Med 1994; 154:1272-1276.
7. Jenkins PJ, Frajese V, Jones AM, camacho-Hubner C, Lowe DG, Fairclough PD, Chew SL, Grossman AB, Monson JP, Besser GM. Insulin-like growth factor I and the development of colorectal neoplasia in acromegaly. J Clin Endocrinol Metab 2000; 85:3218-3221.
8. Dockray GJ, Varro A, Dimaline R, Wang T. The gastrins: their production and biological activities. Annu Rev Physiol 2001; 63:119-139.
9. Szabo I, Rumi G, Bodis B, Nemeth P, Mozsik G. gastrin and pentagastrin enhance the tumor proliferation of human cultured gastric adenocarcinoma cells. J Physiol Paris 2000; 94:71-74.
10. Wright SP. Adjusted P-values for simultaneous inference. Biometrics 1992; 48:1005-1013.
11. Peach HG, Barnett NE. Determinants of basal plasma gastrin levels in the general population. J Gastroenterol Hepatol 2000;15:1267-1271.
12. Dockray GJ. Gastrin, growth, and colon neoplasia. Gut 2000; 47:747-748.
13. Konturek PC, Konturek SJ, Bielanski W, Karczewska E, Pierzchalski P, Duda A, et al. Role of gastrin in gastric carcinogenesis in Helicobacter pylori infected humans. J Physiol Pharmacol 1999; 50:857-873.
14. Henwood M, Clarke PA, Smith AM, Watson SA. Expression of gastrin in developing gastric adenocarcinoma. Br J Surg 2001; 88:564-568.
15. Soran A, Aslar AK, Col C. Are preoperative serum gastrin levels related to resectability and survival in gastric cancer? Int J Clin Pract 2000; 54:652-653.
16. Wang TC, Dangler CA, Chen D, Goldenricg JR, Koh T, raychowdhury R, et al. Synergistic interaction between hypergastrenemia and Helicobacter infection in a mouse model of gastric cancer. Gastroenterology 2000; 118:36-47.
17. Siddheshwar RK, Muhammad KB, Gray JC, Kelly SB. Seroprevalence of Helicobacter pylori in patients with colorectal polyps and colorectal carcinoma. Am J Gastroenterol 2001; 96:84-88.
18. Modlin IM, Tang LH. Cell and tumor biology of the gastric enterochromaffin-like cell. Ital J Gastroenterol Hepatol 1999; suppl 2:SI17-130.
19. Lincoln DT, Kaiser HE, Raju GP, Waters MJ. Growth hormone and colorectal carcinoma: localization of receptors. In Vivo 2000; 14:41-49.
20. Nagano M, Chastre E, Choquet A, Bara J, Crespach C, Kelly PA. Expression of prolactin and growth hormone receptor genes and their isoforms in the gastrointestinal tract. Am J Physiol 1995; 268:G431-442.
21. Smith AM, Watson SA. Gastrin and gastrin receptor activation: an early event in the adenoma-carcinoma sequence. Gut 2000; 47:820-824.
22. Nakata H, Wang SL, Chung DC, Westwick JK, Tillotson LG. Oncogenic ras induce gastrin gene expression in colon cancer. Gastroenterology 1998; 115:1144-1153.
23. Smith AM, Watson SA. Review article: gastrin and colorectal cancer. Aliment Pharmacol Ther 2000; 14:1231-1247.
24. Siddheshwar RK, Gray JC, Kelly SB. Plastna levels of progastrin but not amidated gastrin or glycine extended gastrin are elevated in patients with colorectal carcinoma. Gut 2001; 48:47-52.
25. Lamberts R, Wartenberg T, Creutzfeldt W. role of circulating gastrin in colorectal adenomas and carcinomas. Digestion 1999; 60:101-109.
26. Chen D, Destree M, Hakanson R, Willems G. Endogenous hypergastrinemia does not promote growth of colonic mucosa or of a transplanted adenocarcinoma in rats. Eur J Gastroenterol Hepatol 1998; 10:293-299.
27. Saurin JC, Rouault JP, Abolo J, Berger F, Remy L, Chayvialle JA. High gastrin releasing peptide receptor mRNA level is related to tumor dedifferentiation and lymphatic vessel invasion in human colon cancer. Eur J Cancer 1999; 35:125-132.
28. Watson SA, Smith AM. Hypergastrinemia promotes adenoma progression in the APC (Min±) mouse model of familial adenomatous polyposis. Cancer Res 2001; 61:625-631.
29. Tayek JA, Bulcavage L, Chlebowski RT. Relationship of hepatic glucose production to growth hormone and severity of malnutrition in a population with colorectal carcinoma. Cancer Res 1990; 50:2119-2122.
30. Cascinu S, Del Ferro E, Grianti C, Ligi M, Ghiselli R, Foglietti G, Saba V, Lungarotti F, Catalano G. Inhibition of tumor cell kinetics and serum insulin growth factor I levels by octeotride in colorectal cancer patients. Gastroenterology 1997; 113:767-772.
31. Szepeshazi K, Schally AV, Groot K, Armatis P, Halmos G, Herbert F, Szende B, Varga JL, Zarandi M. Antagonists of growth hormone-releasing hormone (GH-RH) inhibit 1GF-II production and growth of HT-29 human colon cancers. Br J Cancer 2000; 82:1724-1731.
32. Manousos O, Souglakos J, Bosetti C, Tzonou A, Chatzidakis V, Trichopoulos D, Adami HO, Mantzoros C. IGF-I and IGF-II in relation to colorectal cancer. Int J Cancer 1999; 83:15-17.
33. Giovannucci E, Pollak MN, Platz EA, Willett WC, Stampfer MJ, Majeed N, Colditz GA, Speizer FE, Hankinson SE. A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women. Cancer Epidemiol Biomarkers Prev 2000; 9:345-349.
34. Kaaks R, Toniolo P, Akhmedkhanov A, Lukanova A, Biessy C, Dechaud H, Rinaldi S, Zeleniuch-Jacquotte A, Shore RE, Riboli E. Serum C-peptide, insulin-like growth factor (IGF-1), IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst 2000; 92:1592-1600.
35. Howarth GS, Xian CJ, Read LC. Predisposition to colonic dysplasia is unaffected by continuous administration of insulin-like growth factor-I for twenty weeks in a rat model of chronic inflammatory bowel disease. Growth factors. 2000; 18:119-133.
36. Ma J, Pollak MN, Giovannucci E, Chan JM, tao Y, Hennekens CH, Stampfer MJ. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst 1999; 91:620-625.
37. Renehan AG, Painter JE, Atkin WS, Potten CS, Shalet SM, O'Dwyer ST. High-risk colorectal adenomas and serum-like growth factors. Br J Surg 2001; 88:107-113.